SCHEMBL29914907

SCHEMBL29914907

Fc1ccccc1-c1ccc(-c2ccccn2)c(F)c1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.46
LMNA P02545 3/20 0.46
CCR1 P32246 2/20 0.46
CCR5 P51681 2/20 0.46
CCR8 P51685 2/20 0.46
CYP1A2 P05177 1/20 0.46
POLB P06746 1/20 0.46
METAP1 P53582 1/20 0.46
BLM P54132 1/20 0.46
HIF1A Q16665 1/20 0.46
DOHH Q9BU89 1/20 0.46
P4HTM Q9NXG6 1/20 0.46
L3MBTL1 Q9Y468 4/20 0.45
HTT P42858 3/20 0.45
TP53 P04637 3/20 0.45
TDP1 Q9NUW8 2/20 0.45
ALOX15 P16050 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
ALPL P05186 1/20 0.45
HSP90AA1 P07900 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1780998 0.86 KDM4E (0.56) KDM4ELMNACCR1CCR5CCR8
SCHEMBL1356335 0.85 KDM4E (0.50) KDM4ELMNACCR1CCR5CCR8
SCHEMBL30888806 0.85 KDM4E (0.50) KDM4ELMNACCR1CCR5CCR8
SCHEMBL970044 0.85 KDM4E (0.50) KDM4ELMNACCR1CCR5CCR8
SCHEMBL29901541 0.85 KDM4E (0.50) KDM4ELMNACCR1CCR5CCR8
SCHEMBL30022590 0.83 KDM4E (0.48) KDM4ELMNACCR1CCR5CCR8
SCHEMBL29986122 0.83 KDM4E (0.48) KDM4ELMNACCR1CCR5CCR8
SCHEMBL18897003 0.79 NPC1 (0.43) KDM4EL3MBTL1SMN1; SMN2MAPK1NPC1
SCHEMBL12828418 0.76 KDM4E (0.45) KDM4ELMNACCR1CCR5CCR8
SCHEMBL28650048 0.76 KDM4E (0.45) KDM4ELMNACCR1CCR5CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11444250-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2022-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11444250-B2 Composition of matter for use in organic light-emitting diodes CRY2, ALDH1A2, CYBA KDM4E 4374/4885LMNA 1149/4885CCR1 3495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.